Comprehensive analysis of the characteristics and treatment outcomes of patients with non-small cell lung cancer treated with anti-PD-1 therapy in real-world practice.
Ahn, Beung-Chul
Comprehensive analysis of the characteristics and treatment outcomes of patients with non-small cell lung cancer treated with anti-PD-1 therapy in real-world practice. [electronic resource] - Journal of cancer research and clinical oncology Jun 2019 - 1613-1623 p. digital
Publication Type: Journal Article
1432-1335
10.1007/s00432-019-02899-y doi
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Humanized--administration & dosage
Antineoplastic Agents, Immunological--administration & dosage
Carcinoma, Non-Small-Cell Lung--drug therapy
Female
Humans
Lung Neoplasms--drug therapy
Male
Middle Aged
Nivolumab--administration & dosage
Programmed Cell Death 1 Receptor--antagonists & inhibitors
Retrospective Studies
Treatment Outcome
Comprehensive analysis of the characteristics and treatment outcomes of patients with non-small cell lung cancer treated with anti-PD-1 therapy in real-world practice. [electronic resource] - Journal of cancer research and clinical oncology Jun 2019 - 1613-1623 p. digital
Publication Type: Journal Article
1432-1335
10.1007/s00432-019-02899-y doi
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Humanized--administration & dosage
Antineoplastic Agents, Immunological--administration & dosage
Carcinoma, Non-Small-Cell Lung--drug therapy
Female
Humans
Lung Neoplasms--drug therapy
Male
Middle Aged
Nivolumab--administration & dosage
Programmed Cell Death 1 Receptor--antagonists & inhibitors
Retrospective Studies
Treatment Outcome